Representative before the EPO

Employment test 51 - 200 employees
Company dna carpmarls and ransford
operating since 1848
Headquarter in London and 2 offices
active in Legal Services and IP Consulting

Rachel Margaret Bullett has worked on the following 12 EPO patent applications which have been published in the last five years:

EP12176076

Single pluripotent stem cell culture

IPC classification:
C12N 5/0735
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11848160

COMPOSITIONS AND METHODS FOR SPINE FUSION PROCEDURES

IPC classification:
A61B 17/58
Agent:
Lavoix Munich
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION REQUESTED
EP11799567

TISSUE ENGINEERED BLOOD VESSELS

IPC classification:
A61L 27/18, A61L 27/36, A61L 27/38, A61L 27/50
Applicant:
Cordis Corporation
Agent:
Thomas Prock, Marks & Clerk LLP
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP12729758

MCAM ANTAGONISTS AND METHODS OF TREATMENT

IPC classification:
C07K 16/30
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13163291

Treatment of pluripotent cells

IPC classification:
C12N 5/0735
Applicant:
Janssen Biotech, Inc.
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP13155730

Ex-vivo priming for generating cytotoxic T lymphocytes specific for non-tumor antigens to treat autoimmune and allergic disease

IPC classification:
C12N 5/07, C12N 5/071
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
GRANT OF PATENT INTENDED
EP11700973

EV576 FOR USE IN THE TREATMENT OF VIRAL INFECTIONS OF THE RESPIRATORY TRACT

IPC classification:
A61K 38/16, A61P 31/16
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
EXAMINATION IN PROGRESS
EP11733896

SELF-DELETING PLASMID

IPC classification:
C12N 15/64
Agent:
Rachel Margaret Bullett, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12197549

Compositions comprising pneumococcal antigens

IPC classification:
A61K 39/09, C07K 14/315, C07K 19/00, C12N 1/21
Applicant:
GlaxoSmithKline Biologicals SA
Applicant:
Novartis AG
Agent:
Rachel Margaret Bullett, Carpmaels & Ransford LLP
Agent:
Antoine Courgeon, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP12700043

TUMOUR CELL AND TISSUE CULTURE

IPC classification:
C12N 5/09, G01N 33/50
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11745456

PLATELET-DERIVED GROWTH FACTOR COMPOSITIONS AND METHODS FOR THE TREATMENT OF TENDINOPATHIES

IPC classification:
A61P 19/00
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP10795525

METHOD OF RENAL REPAIR AND REGENERATION AND THE TREATMENT OF DIABETIC NEPHROPATHY

IPC classification:
A61K 35/22, A61P 13/12
Applicant:
DePuy Synthes Products, Inc.
Agent:
Multiple attorneys, Carpmaels & Ransford LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT

Please Sign in to use this feature